Figure 2.
Concentration of cytokines through cultures of PBMCs derived from peripheral blood of the patient groups evaluated by CBA (cytometric bead array): Healthy control, RR (patients with relapse–remitting multiple sclerosis), SP (patients with secondary progressive multiple sclerosis). (A) IL-2, (B) IL-4, (C) IFN-γ, (D) IL-10, (E) IL-17, (F) TNF-α, and (G) IL-6. Rows represent the median. Statistical analysis was performed using the Kruskal–Wallis test with Dunn’s post-test, where * p < 0.05.